Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-12

Clinical Trial Update: Effects of Botox in Obstructed Defecation Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the effects of Botox in obstructed defecation syndrome (ODS) has been terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Obstructed Defecation Syndrome (ODS) | Phase 2 | Status: TERMINATED | Results posted: 2020-05-12